{
    "Trade/Device Name(s)": [
        "UASure II Blood Uric Acid Monitoring System"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K242209",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160990"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "PTC"
    ],
    "Summary Letter Date": "February 25, 2025",
    "Summary Letter Received Date": "February 25, 2025",
    "Submission Date": "July 24, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.1775"
    ],
    "Regulation Name(s)": [
        "Uric acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Uric acid"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "UASure II Blood Uric Acid Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for UASure II Blood Uric Acid Monitoring System using amperometry for self-monitoring of blood uric acid at home",
    "Indications for Use Summary": "Intended for self-testing of blood uric acid levels in fresh capillary whole blood from the fingertip by people with gout to monitor effectiveness of uric acid control at home by prescription, not for diagnosis or medication adjustment without physician consultation",
    "fda_folder": "Clinical Chemistry"
}